Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lafutidine vs placebo and famotidine in mild reflux esophagitis
jRCT2080220050Phase 3
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lafutidine in erosive esophagitis (EE) (3 arms), sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
lafutidine
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on jRCT2080220050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220050.